Actinium Pharmaceuticals, Inc.
ATNM· NYSE
ATNMActinium Pharmaceuticals, Inc.
Filed May 10, 2018 · 10-Q · 40 days after period end · 0001213900-18-005849
| Metric | Q1 2018 | Q1 2017 | Q1 2016 | Q1 2015 |
|---|---|---|---|---|
| Net Income | -$6.32M | -$8.06M | -$4.40M | -$3.07M |
| EPS Diluted | -$0.07 | -$0.14 | -$0.10 | -$0.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Actinium Pharmaceuticals, Inc. · CIK 1388320 · Engraved from SEC EDGAR
ended Mar 31, 2018 · filed May 10, 2018 · 40 d after period end
